Advanced search
Publication Cover
Journal of Asthma Volume 34, 1997 - Issue 3
Submit an article Journal homepage
64
Views
33
CrossRef citations to date
0
Altmetric
Original Article

Impact of Fluticasone Propionate Powder on Health-Related Quality of Life in Patients with Moderate Asthma

Puneet Mahajan Glaxo Wellcome Inc., Research Triangle Park, North Carolina
,
Lynn J. Okamoto Glaxo Wellcome Inc., Research Triangle Park, North Carolina
,
Amy Schaberg Glaxo Wellcome Inc., Research Triangle Park, North Carolina
,
Don Kellerman Glaxo Wellcome Inc., Research Triangle Park, North Carolina
&
William F. Schoenwetter Park Nicollet Medical Center, Minneapolis, Minnesota
Pages 227-234 | Published online: 02 Jul 2009

References

  • Hume K M, Rhys Jones E. Bronchodilators and corticosteroids in asthma: Forced expiratory volume as an aid to diagnosis and treatment. Lancet 1960; 2: 1319–1322
  • Busse W W, Wilson AF. Task force on guidelines for clinical investigation of nonbronchodilator antiasthmatic drugs: Assessment of efficacy. J Allergy Clin Immunol 1986; 78: 525–528
  • Juniper F E, Daniel E E, Robert R S, Kline P A, Har-greave F E, Newhouse MT. Improvement in airway responsiveness and clinical asthma severity during pregnancy. Am RevRespir Dis 1989; 140: 924–931
  • Ware JE. Conceptualizing disease impact and treatment outcomes. Cancer 1984; 53: 2316–2326, (Suppl)
  • Wenger NK. Quality-of-Life considerations in new drug development. QOL Cardiovasc Care Au-tumn 1988; 128–130
  • Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. New England Medical Center, Boston 1993
  • Ware JE. Conceptualizing and measuring generic health outcomes. Cancer 1991; 67: 774–779, (Suppl)
  • Hyland ME. The Living with Asthma Questionnaire. Respir Med. 1991; 85: 13–16, (Suppl B)
  • Juniper E F, Guyatt G H, Ferrie P J, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832–838
  • Conclusions and Recommendations. Med Care 1993; 31(2)MS4–MS8, (Suppl)
  • Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84: 25–29, (Suppl A)
  • Chervinsky P, Van As A, Bronsky E A, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immu nol 1994; 94: 676–683
  • Noonan M, Chervinsky P, Busse W W, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995; 152(5)1467–1473
  • Okamoto L J, Noonan M, De Boisblanc B P, Kellerman DJ. Fluticasone propionate improves quality of life in patients with asthma requiring oral corticosteroids. Ann Allergy Asthma Immunol 1996, in press
  • Richards J M, Hemstreet MP. Measures of life quality, role performance, and functional status in asthma research. Am J Respir Crit Care Med 1994; 149: S31–S39, (2 Pt 2)
  • Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 236: 225–244
  • Hyland M E, Kenyon C AP, Jacobs PA. Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics. QOL Res 1994; 3: 121–126
  • Hyland M E, Finnis S., Irvine SH. A scale for assessing quality of life in adult asthma sufferers. J Pyschosom Res 1991; 35(1)99–110
  • Boyer G, Aaronson D, Meltzer E, Laforce C, Grossman J, Yancey S. Enhancement of a general quality of life scale: Validation of a sleep scale. J Allergy Clin Immunol 1992; 89: 186, (Suppl 1, part 2)
  • Hays R D, Hayashi T, Carson S, Ware JE. User's Guide for the Multitrait Analysis Program (MAP). A Rand Note. November, 1988
  • Pearlman D, Noonan M, Tashkin D, et al. Efficacy of inhaled fluticasone propionate (FP) powder in asthma. J Allergy Clin Immunol 1995; 95: 313, (1, pt 2) (abstract 690)
  • Viramontes J L, O'Brien B. Relationship between symptoms and health-related quality of life in chronic lung disease. J Gen Intern Med 1994; 9(1)46–48
  • Palmer J BD, Hyland ME. Salmeterol in clinical practice: Comparator and safety studies, quality of life studies. Eur Respir Rev 1991; 1(4)301–303
  • Martin RJ. Nocturnal asthma: Circadian rhythms and therapeutic interventions. Am Rev Respir Dis 1993; 147: S25–S28
  • Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85: 6–8
  • Wasserman S I, Gross G N, Schoenwettter W F, Munk Z M, Krai KM. A 12-week dose-ranging study of fluticasone propionate powder in the treatment of asthma. J Asthma (1996) 1996; 33(4)265–274
  • Hummel S, Lehtonen L. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroids in maintenance treatment of severe asthma. Lancet 1992; 340: 1483–1487
  • Gaddie J, Reid I W, Skinner C, et al. Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma. Lancet 1973; 2: 280–281

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.